Doug Wilson
Follow
Get notifications in MyBN when activity occurs.
Doug Wilson
Non-Executive Director / AFT Pharmaceuticals
Dr Doug Wilson is a New Zealand medical graduate with postgraduate experience in London at St Thomas Hospital Medical School, and at Walter and Eliza Hall Institute Melbourne.
Dr Wilson joined the international pharmaceutical industry and became senior vice president for Boehringer Ingeleim for Medicine and regulatory affairs in the USA where he was responsible for all dealings with FDA. He moved to Ingelheim and had the same responsibilities worldwide. Dr Wilson headed the company’s international labelling committee, was deputy head of the International Medical Committee which oversaw all drugs in clinical development globally, and saw ten drugs approved in the USA during his tenure.
Dr Wilson joined the international pharmaceutical industry and became senior vice president for Boehringer Ingeleim for Medicine and regulatory affairs in the USA where he was responsible for all dealings with FDA. He moved to Ingelheim and had the same responsibilities worldwide. Dr Wilson headed the company’s international labelling committee, was deputy head of the International Medical Committee which oversaw all drugs in clinical development globally, and saw ten drugs approved in the USA during his tenure.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 378th | Countplus | 22% | 8% |
| 435th | MedAdvisor | 17% | 3% |
| 795th | AFT Pharmaceuticals | -4% | 9% |
| 1578th | Betmakers Technology Group | -57% | 22% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 389th |  | AFT Pharmaceuticals | $145.7m |
| 458th | | MedAdvisor | $98.0m |
| 459th | | Countplus | $96.3m |
| 461st | | Betmakers Technology Group | $96.2m |
| 462nd | | Webcentral Group | $96.2m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, AFT Pharmaceuticals | 03 Nov 2020 |
